🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to evaluate the efficacy and safety of convers...
Status
Completed
Location
Shandong Cancer Hospital and Institute
Start Date
2021-03-17
Trial ID
NCT05099848
Treatments Being Tested
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
This is a single-arm, single-center feasibility trial of patients with bord...
Status
Recruiting
Location
Juravinski Hospital
Start Date
2021-03-01
Trial ID
NCT04452461
Treatments Being Tested
Approximately 40% of colorectal cancer patients will develop colorectal liv...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System
Start Date
2021-11-01
Trial ID
NCT05103020
The aim of this study is to evaluate the synergistic anti-tumor effect of C...
Status
Unknown
Location
Jiege Huo
Start Date
2015-06
Trial ID
NCT02510118
Treatments Being Tested
Use lay language. Oxaliplatin is a reference anticancer drug in the treatme...
Status
Completed
Location
CHU de Clermont-Ferrand
Start Date
2013-02-02
Trial ID
NCT01775449
Treatments Being Tested
Rectal cancer still remains one of the most popular tumors, however, distan...
Status
Recruiting
Location
Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences,
Start Date
2023-02-03
Trial ID
NCT05601505
Treatments Being Tested
dMMR/MSI-H is a key molecular subtype of gastric cancer, found in 8-22% of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-31
Trial ID
NCT07259473
Treatments Being Tested
Our main objective is to evaluate the effect of Ocoxin-Viusid on the qualit...
Status
Completed
Location
National Institute of Oncology and Radiobiology (INOR)
Start Date
2018-10-25
Trial ID
NCT03549494
Treatments Being Tested